Tag: vital-medicines

South Africa is in talks with Swiss pharmaceutical firm Roche to reduce the price of its breast cancer drug Herceptin, which currently costs 500,000 rand ($33,000) a year to treat one person and is unaffordable to most women, the health minister said on Tuesday. Africa's most industrialised country has a history of pushing to cut…